David B. Ring

Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo

David B. Ring, Kirk W. Johnson, Erik J. Henriksen et al. · Diabetes · 2003 · 555 citations · Full text

Life Sciences, Biochemistry, Endocrinology +15

Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

Louis M. Weiner, Joseph I. Clark, Michael P. Davey et al. · PubMed · 1995 · 140 citations

Medicine, Oncology, Pharmacology +17

Evaluation of monoclonal antibodies for the development of breast cancer immunotoxins.

M J Bjorn, David B. Ring, Arthur E. Frankel · PubMed · 1985 · 116 citations

Pharmacy, Oncology, Toxicology +14

Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats

Erik J. Henriksen, Tyson R. Kinnick, Mary K. Teachey et al. · American Journal of Physiology-Endocrinology and Metabolism · 2003 · 108 citations

Life Sciences, Endocrinology, Physiology +16

Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies.

Arthur E. Frankel, David B. Ring, F Tringale et al. · PubMed · 1985 · 87 citations

Medicine, Cancer Biology, Oncology +17